5 Cheap Biotech Stocks Smart Investors Are Piling Into

4. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Investors In Q2 2023: 43

P/E Ratio: 44.13

Novo Nordisk A/S (NYSE:NVO) is a global pharmaceutical giant with close to sixty thousand employees. While the firm’s famous weight loss drug Ozempic is quite popular among users, it is also generating worries from Walmart about its ability to reduce food sales at the world’s largest retailer.

After digging through 910 hedge funds for their second quarter of 2023 shareholdings, Insider Monkey discovered that 43 had bought the firm’s shares. Novo Nordisk A/S (NYSE:NVO)’s biggest hedge fund investor is Jim Simons’ Renaissance Technologies due to its $1.5 billion stake.

Follow Novo Nordisk A S (NYSE:NVO)